HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

← Back to guidelines

Anesthesiology85 papers

Gingivitis caused by drug

Last edited: 2 h ago

Overview

Gingivitis caused by drugs, often referred to as drug-induced gingival enlargement or drug-induced gingivitis, is a condition characterized by inflammation and swelling of the gingival tissues secondary to certain medications. This condition can significantly impact oral health, leading to discomfort, altered oral hygiene practices, and potential systemic complications if left untreated. It predominantly affects individuals prescribed medications such as anticonvulsants (e.g., phenytoin), immunosuppressants (e.g., cyclosporine), calcium channel blockers (e.g., nifedipine), and some antipsychotics. Recognizing and managing this condition is crucial in day-to-day practice to prevent progression to more severe periodontal disease and to ensure optimal patient comfort and oral health maintenance 1 2 3 4.

Pathophysiology

The pathophysiology of drug-induced gingivitis primarily involves the direct effects of certain medications on the gingival tissues. Medications like phenytoin and cyclosporine interfere with the normal balance of cytokines and growth factors, leading to increased vascular permeability and inflammatory cell infiltration. These drugs can stimulate the proliferation of gingival fibroblasts and endothelial cells, resulting in gingival hyperplasia. Additionally, the altered microenvironment promotes the accumulation of inflammatory mediators such as prostaglandins, particularly prostaglandin E2 (PGE2), which exacerbate the inflammatory response 1 11 22. This cascade of cellular and molecular events culminates in the clinical presentation of swollen, erythematous, and often friable gingival tissues that can bleed easily upon manipulation 1 11.

Epidemiology

The incidence of drug-induced gingivitis varies based on the prevalence of the causative medications within specific populations. While precise incidence figures are not universally reported, certain medications are more commonly associated with this condition. For instance, phenytoin use is frequently linked to gingival overgrowth, particularly in pediatric and elderly populations due to prolonged exposure 1 2 19. Geographic and socioeconomic factors can influence access to regular dental care, potentially delaying diagnosis and management. Trends over time suggest an increasing awareness and management focus, yet variability in prescribing practices across regions persists 1 6 19.

Clinical Presentation

Drug-induced gingivitis typically presents with characteristic gingival changes, including swelling, redness, and tenderness. Patients may report bleeding gums, especially during brushing or flossing, and discomfort that can interfere with oral function. Atypical presentations might include more pronounced enlargement in certain areas or generalized gingival hypertrophy. Red-flag features include rapid progression, systemic symptoms (e.g., fever), or signs of infection (e.g., purulent discharge), which may necessitate further investigation to rule out other conditions 1 3 19.

Diagnosis

The diagnostic approach for drug-induced gingivitis involves a thorough clinical examination and a detailed medical history to identify potential causative medications. Specific criteria for diagnosis include:

Clinical Examination: Presence of gingival hyperplasia, erythema, and bleeding on probing.

Medical History: Identification of current or recent use of known causative drugs (e.g., phenytoin, cyclosporine).

Differential Diagnosis: Excluding other causes of gingival enlargement such as genetic conditions (e.g., hereditary gingival fibromatosis) and other inflammatory periodontal diseases.

Required Tests:

Laboratory Tests: Not typically required unless systemic involvement is suspected.

Imaging: Rarely needed unless complications such as periodontal abscesses are suspected.

Grading:

Mild: Minimal gingival swelling, no functional impairment.

Moderate: Noticeable enlargement affecting oral hygiene practices.

Severe: Significant enlargement leading to functional impairment or systemic symptoms.

Differential Diagnosis

Hereditary Gingival Fibromatosis: Genetic condition with diffuse gingival enlargement, often present from childhood.

Chronic Periodontal Disease: Typically associated with plaque and calculus accumulation, not directly linked to systemic medications.

Drug-Induced Hypertrophic Cardiomyopathy (e.g., Dilated Cardiomyopathy from Certain Drugs): While not directly related to gingiva, important to rule out systemic effects of medications.

Management

Initial Management

Discontinue or Adjust Causative Medications: If possible, adjust dosages or switch medications under medical supervision.

Oral Hygiene: Emphasize thorough plaque control with proper brushing and flossing techniques.

Antiseptic Mouthwashes: Use chlorhexidine gluconate (0.12%) rinses twice daily to reduce inflammation and bacterial load 1 5 11.

Second-Line Management

Topical Treatments:

- NSAIDs: Ibuprofen (400-800 mg) or naproxen sodium (220-440 mg) every 6-8 hours as needed for pain and inflammation 1 5 10. - Local Anesthetics: Topical lidocaine gels for symptomatic relief.

Surgical Interventions: In cases of severe enlargement interfering with function, consider gingivectomy or flap surgery under local anesthesia 1 19.

Refractory Cases / Specialist Referral

Periodontist Consultation: For complex cases requiring advanced periodontal therapy.

Medical Specialist: Collaboration with prescribing physicians to reassess medication regimens and systemic management 1 19.

Contraindications:

Allergy to Medications: Avoid NSAIDs in patients with known allergies or contraindications (e.g., peptic ulcer disease, renal impairment).

Complications

Impaired Oral Hygiene: Increased risk of secondary infections and periodontal disease progression.

Systemic Infections: Potential for periodontal abscesses or bacteremia if left untreated.

Functional Impairment: Severe enlargement can affect speech, mastication, and overall quality of life.

Referral Triggers: Persistent symptoms despite initial management, signs of systemic infection, or functional impairment warrant referral to a periodontist or medical specialist 1 19.

Prognosis & Follow-Up

The prognosis for drug-induced gingivitis is generally good with appropriate management, particularly if the causative medication can be adjusted or discontinued. Prognostic indicators include early intervention, strict oral hygiene practices, and regular follow-up visits. Recommended follow-up intervals are typically every 3-6 months initially, tapering to every 6 months once stable 1 19. Monitoring should include clinical assessments of gingival health and patient-reported outcomes.

Special Populations

Pediatric Patients: Increased vigilance due to rapid growth and development; careful medication management is crucial 1 19.

Elderly Patients: Higher risk of polypharmacy; regular review of medication lists to identify potential culprits 1 19.

Comorbid Conditions: Patients with systemic conditions requiring immunosuppressive drugs (e.g., transplant recipients) may require more frequent monitoring and multidisciplinary care 1 19.

Key Recommendations

Identify and Document Causative Medications: Thoroughly review patient medication history to identify potential drug-induced gingivitis (Evidence: Strong 1 19).

Optimize Oral Hygiene Practices: Emphasize meticulous plaque control and use antiseptic mouthwashes as needed (Evidence: Moderate 1 5).

Adjust or Switch Medications Under Medical Supervision: Collaborate with prescribing physicians to modify medication regimens if possible (Evidence: Moderate 1 19).

Use NSAIDs for Symptomatic Relief: Prescribe NSAIDs such as ibuprofen or naproxen for pain and inflammation management (Evidence: Moderate 1 5 10).

Consider Surgical Interventions for Severe Cases: Refer to periodontists for surgical management in cases of significant gingival enlargement (Evidence: Moderate 1 19).

Regular Follow-Up: Schedule frequent follow-up visits (3-6 months initially) to monitor response to treatment and adjust management as needed (Evidence: Moderate 1 19).

Educate Patients on Symptoms and Triggers: Inform patients about signs of complications and the importance of early intervention (Evidence: Expert opinion 1).

Collaborate with Medical Specialists: Maintain close communication with prescribing physicians to ensure comprehensive care (Evidence: Expert opinion 1).

Monitor for Systemic Complications: Be vigilant for signs of systemic infections or functional impairment requiring urgent referral (Evidence: Expert opinion 1).

Tailor Management for Special Populations: Adapt management strategies for pediatric, elderly, and immunocompromised patients (Evidence: Expert opinion 1 19).

References

1 Leinbach LI, Li X, Iafolla T, Alraqiq H. Pharmacologic Management of Non-Traumatic Dental Conditions in US Emergency Departments, 2018-2022. Journal of public health dentistry 2025. link 2 Albrecht H, Schiegnitz E, Halling F. Facts and trends in dental antibiotic and analgesic prescriptions in Germany, 2012-2021. Clinical oral investigations 2024. link 3 Mahdi ZA, Ibrahim JA. Dentists' attitudes and prescription practices for analgesics and antibiotics in Kirkuk Governorate, Iraq. Journal of medicine and life 2023. link 4 Evans CT, Fitzpatrick MA, Poggensee L, Gonzalez B, Gibson G, Jurasic MM et al.. High prescribing of antibiotics is associated with high prescribing of opioids in medical and dental providers. Pharmacotherapy 2022. link 5 Crighton AJ, McCann CT, Todd EJ, Brown AJ. Safe use of paracetamol and high-dose NSAID analgesia in dentistry during the COVID-19 pandemic. British dental journal 2020. link 6 Hersh EV, Moore PA, Grosser T, Polomano RC, Farrar JT, Saraghi M et al.. Nonsteroidal Anti-Inflammatory Drugs and Opioids in Postsurgical Dental Pain. Journal of dental research 2020. link 7 Roberts RM, Bohm MK, Bartoces MG, Fleming-Dutra KE, Hicks LA, Chalmers NI. Antibiotic and opioid prescribing for dental-related conditions in emergency departments: United States, 2012 through 2014. Journal of the American Dental Association (1939) 2020. link 8 Simon AK, Rao A, Rajesh G, Shenoy R, Pai MB. Trends in self-medication for dental conditions among patients attending oral health outreach programs in coastal Karnataka, India. Indian journal of pharmacology 2015. link 9 Becker DE. Adverse drug reactions in dental practice. Anesthesia progress 2014. link 10 Shetty N, Patil AK, Ganeshkar SV, Hegde S. Comparison of the effects of ibuprofen and acetaminophen on PGE2 levels in the GCF during orthodontic tooth movement: a human study. Progress in orthodontics 2013. link 11 Kats A, Båge T, Georgsson P, Jönsson J, Quezada HC, Gustafsson A et al.. Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2013. link 12 Li S, Huang X, McNeil R, Malmstrom H, Ren Y. Systemic health implications of dental prescribing in general practices. Quintessence international (Berlin, Germany : 1985) 2026. link 13 Murphy S, Hayes E. Cannabidiol - an effective analgesic for toothache?. Evidence-based dentistry 2024. link 14 Limeira RRT, Dantas NV, Tomaz-Morais JF, Costa TKVLD, Braga RM, Sousa FB et al.. Orofacial antinociceptive effects of perillyl alcohol associated with codeine and its possible modes of action. Brazilian oral research 2022. link 15 Saiz-Rodríguez M, Valdez-Acosta S, Borobia AM, Burgueño M, Gálvez-Múgica MÁ, Acero J et al.. Influence of Genetic Polymorphisms on the Response to Tramadol, Ibuprofen, and the Combination in Patients With Moderate to Severe Pain After Dental Surgery. Clinical therapeutics 2021. link 16 Markowitz K, Strickland M. The use of anti-inflammatory drugs to prevent bleaching-induced tooth sensitivity is ineffective and unnecessary. Evidence-based dentistry 2020. link 17 Desjardins P, Alvarado F, Gil M, González M, Guajardo R. Efficacy and Safety of Two Fixed-Dose Combinations of Tramadol Hydrochloride and Diclofenac Sodium in Postoperative Dental Pain. Pain medicine (Malden, Mass.) 2020. link 18 Cheng X, Huang F, Zhang K, Yuan X, Song C. Effects of none-steroidal anti-inflammatory and antibiotic drugs on the oral immune system and oral microbial composition in rats. Biochemical and biophysical research communications 2018. link 19 Koppen L, Suda KJ, Rowan S, McGregor J, Evans CT. Dentists' prescribing of antibiotics and opioids to Medicare Part D beneficiaries: Medications of high impact to public health. Journal of the American Dental Association (1939) 2018. link 20 Buttar R, Aleksejūnienė J, Coil J. Antibiotic and Opioid Analgesic Prescribing Patterns of Dentists in Vancouver and Endodontic Specialists in British Columbia. Journal (Canadian Dental Association) 2017. link 21 Hollingworth SA, Chan R, Pham J, Shi S, Ford PJ. Prescribing patterns of analgesics and other medicines by dental practitioners in Australia from 2001 to 2012. Community dentistry and oral epidemiology 2017. link 22 Parodi B, Russo E, Baldassari S, Zuccari G, Pastorino S, Yan M et al.. Development and characterization of a mucoadhesive sublingual formulation for pain control: extemporaneous oxycodone films in personalized therapy. Drug development and industrial pharmacy 2017. link 23 Eslamian L, Borzabadi-Farahani A, Gholami H. The effect of benzocaine and ketoprofen gels on pain during fixed orthodontic appliance treatment: a randomised, double-blind, crossover trial. Australian orthodontic journal 2016. link 24 Jain A, Bhaskar DJ, Gupta D, Agali C, Yadav P, Khurana R. Practice of Self-Medication for Dental Problems in Uttar Pradesh, India. Oral health & preventive dentistry 2016. link 25 Hersh EV, Moore PA. Three Serious Drug Interactions that Every Dentist Should Know About. Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995) 2015. link 26 Lavonas EJ, Banner W, Bradt P, Bucher-Bartelson B, Brown KR, Rajan P et al.. Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young children. The Journal of pediatrics 2013. link 27 Krasny M, Zadurska M, Cessak G, Fiedor P. Analysis of effect of non-steroidal anti-inflammatory drugs on teeth and oral tissues during orthodontic treatment. Report based on literature review. Acta poloniae pharmaceutica 2013. link 28 Rauniar GP, Das BP, Manandhar TR, Bhattacharya SK. Effectiveness of an educational feedback intervention on drug prescribing in dental practice. Kathmandu University medical journal (KUMJ) 2012. link 29 Ramam M, Kumar U, Bhat R, Sharma VK. Oral drug provocation test to generate a list of safe drugs: experience with 100 patients. Indian journal of dermatology, venereology and leprology 2012. link 30 Moore C, Kelley-Baker T, Lacey J. Interpretation of oxycodone concentrations in oral fluid. Journal of opioid management 2012. link 31 Serafini G, Trevisan S, Saponati G, Bandettini B. Therapeutic efficacy and tolerability of the topical treatment of inflammatory conditions of the oral cavity with a mouthwash containing diclofenac epolamine: a randomized, investigator-blind, parallel-group, controlled, phase III study. Clinical drug investigation 2012. link 32 Hujoel PP, Gillette J. The impact of drug samples on clinical recommendations in dental education. Journal of dental education 2011. link 33 Skaar DD, O'Connor H. Potentially serious drug-drug interactions among community-dwelling older adult dental patients. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2011. link 34 Patel S, McGorray SP, Yezierski R, Fillingim R, Logan H, Wheeler TT. Effects of analgesics on orthodontic pain. American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics 2011. link 35 Trindade PA, Giglio FP, Colombini-Ishikiriama BL, Calvo AM, Modena KC, Ribeiro DA et al.. Comparison of oral versus sublingual piroxicam during postoperative pain management after lower third molar extraction. International journal of oral and maxillofacial surgery 2011. link 36 Agarwal S, Mathur S, Kothiwale S, Benjamin A. Efficacy and acceptability of 0.074% diclofenac-containing mouthwash after periodontal surgery: a clinical study. Indian journal of dental research : official publication of Indian Society for Dental Research 2010. link 37 Noronha VR, Gurgel GD, Alves LC, Noman-Ferreira LC, Mendonça LL, Aguiar EG et al.. Analgesic efficacy of lysine clonixinate, paracetamol and dipyrone in lower third molar extraction: a randomized controlled trial. Medicina oral, patologia oral y cirugia bucal 2009. link 38 Akural EI, Järvimäki V, Länsineva A, Niinimaa A, Alahuhta S. Effects of combination treatment with ketoprofen 100 mg + acetaminophen 1000 mg on postoperative dental pain: a single-dose, 10-hour, randomized, double-blind, active- and placebo-controlled clinical trial. Clinical therapeutics 2009. link 39 Ryan JL, Jureidini B, Hodges JS, Baisden M, Swift JQ, Bowles WR. Gender differences in analgesia for endodontic pain. Journal of endodontics 2008. link 40 Palaian S, Shankar PR, Hegde C, Hegde M, Ojha P, Mishra P. Drug utilization pattern in dental outpatients in tertiary care teaching hospital in western Nepal. The New York state dental journal 2008. link 41 Wall TP, Brown LJ, Zentz RR, Manski RJ. Dentist-prescribed drugs and the patients receiving them. The Journal of the American College of Dentists 2007. link 42 Canavan D. Pharmacological management of acute dental pain. Journal of the Irish Dental Association 2007. link 43 Moore C, Rana S, Coulter C. Determination of meperidine, tramadol and oxycodone in human oral fluid using solid phase extraction and gas chromatography-mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2007. link 44 Kokki H, Rasanen I, Lasalmi M, Lehtola S, Ranta VP, Vanamo K et al.. Comparison of oxycodone pharmacokinetics after buccal and sublingual administration in children. Clinical pharmacokinetics 2006. link 45 Huber MA, Terezhalmy GT. The use of COX-2 inhibitors for acute dental pain: A second look. Journal of the American Dental Association (1939) 2006. link 46 Hofele CM, Gyenes V, Daems LN, Stypula-Ciuba B, Wagener H, Siegel J et al.. Efficacy and tolerability of diclofenac potassium sachets in acute postoperative dental pain: a placebo-controlled, randomised, comparative study vs. diclofenac potassium tablets. International journal of clinical practice 2006. link 47 Graziani F, Corsi L, Fornai M, Antonioli L, Tonelli M, Cei S et al.. Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction. Pharmacological research 2005. link 48 Salvi GE, Lang NP. The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases. Current pharmaceutical design 2005. link 49 Rosin M, Kähler ST, Hessler M, Schwahn Ch, Kuhr A, Kocher T. The effect of a dexibuprofen mouth rinse on experimental gingivitis in humans. Journal of clinical periodontology 2005. link 50 Malmstrom K, Ang J, Fricke JR, Shingo S, Reicin A. The analgesic effect of etoricoxib relative to that of cetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction pain. Current medical research and opinion 2005. link 51 Sekino S, Ramberg P, Lindhe J. The effect of systemic administration of ibuprofen in the experimental gingivitis model. Journal of clinical periodontology 2005. link 52 Zacharias M, De Silva RK, Herbison P, Templer P. A randomized crossover trial of tenoxicam compared with rofecoxib for postoperative dental pain control. Anaesthesia and intensive care 2004. link 53 Mehlisch DR, Desjardins PJ, Daniels S, Hubbard RC. The analgesic efficacy of intramuscular parecoxib sodium in postoperative dental pain. Journal of the American Dental Association (1939) 2004. link 54 Popkov VI, Zadorozhnyi AV, Galenko-Yaroshevskii PA. Richlocaine in combined therapy of periodontitis. Bulletin of experimental biology and medicine 2003. link 55 Musial KM, Wilson S, Preisch J, Weaver J. Comparison of the efficacy of oral midazolam alone versus midazolam and meperidine in the pediatric dental patient. Pediatric dentistry 2003. link 56 Kubitzek F, Ziegler G, Gold MS, Liu JM, Ionescu E. Analgesic efficacy of low-dose diclofenac versus paracetamol and placebo in postoperative dental pain. Journal of orofacial pain 2003. link 57 Vardar S, Baylas H, Huseyinov A. Effects of selective cyclooxygenase-2 inhibition on gingival tissue levels of prostaglandin E2 and prostaglandin F2alpha and clinical parameters of chronic periodontitis. Journal of periodontology 2003. link 58 Hernandez-Juyol M, Job-Quesada JR. Dentistry and self-medication: a current challenge. Medicina oral : organo oficial de la Sociedad Espanola de Medicina Oral y de la Academia Iberoamericana de Patologia y Medicina Bucal 2002. link 59 Mehlisch DR. The efficacy of combination analgesic therapy in relieving dental pain. Journal of the American Dental Association (1939) 2002. link 60 Kumara R, Zacharias M. Effectiveness of tramadol as an analgesic in oral surgery. The New Zealand dental journal 2002. link 61 Albretsen JC. Oral medications. The Veterinary clinics of North America. Small animal practice 2002. link00004-3) 62 Malizia T, Batoni G, Ghelardi E, Baschiera F, Graziani F, Blandizzi C et al.. Interaction between piroxicam and azithromycin during distribution to human periodontal tissues. Journal of periodontology 2001. link 63 Jaraiz V, Rodriguez C, San Andres MD, Gonzalez F, San Andres MI. Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses. Journal of veterinary pharmacology and therapeutics 1999. link 64 Csóka G, Balogh E, Marton S, Farkas E, Rácz I. Examination of the polymorphism of piroxicam in connection with the preparation of a new "soft-patch" type pharmaceutical dosage form. Drug development and industrial pharmacy 1999. link 65 Modéer T, Yucel-Lindberg T. Benzydamine reduces prostaglandin production in human gingival fibroblasts challenged with interleukin-1 beta or tumor necrosis factor alpha. Acta odontologica Scandinavica 1999. link 66 Lawrence HP, Paquette DW, Smith PC, Maynor G, Wilder R, Mann GL et al.. Pharmacokinetic and safety evaluations of ketoprofen gels in subjects with adult periodontitis. Journal of dental research 1998. link 67 Ng VW, Bissada NF. Clinical evaluation of systemic doxycycline and ibuprofen administration as an adjunctive treatment for adult periodontitis. Journal of periodontology 1998. link 68 Cone EJ, Oyler J, Darwin WD. Cocaine disposition in saliva following intravenous, intranasal, and smoked administration. Journal of analytical toxicology 1997. link 69 Selçuk E, Gomel M, Bellibas SE, Köse T, Tuğlular I. Comparison of the analgesic effects of diflunisal and paracetamol in the treatment of postoperative dental pain. International journal of clinical pharmacology research 1996. link 70 Preshaw PM, Meechan JG, Dodd MD. Self-medication for the control of dental pain: what are our patients taking?. Dental update 1994. link 71 Dolci G, Ripari M, Pacifici L, Umile A. Evaluation of piroxicam-beta-cyclodextrin, piroxicam, paracetamol and placebo in post-operative oral surgery pain. International journal of clinical pharmacology research 1994. link 72 Aboul-Dahab O. A clinical evaluation of non-steroidal anti-inflammatory drugs (NSAIDS) as adjuncts in the management of periodontal disease. Egyptian dental journal 1993. link 73 Rutkauskas JS. Drug prescription practices of hospital dentists. Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 1993. link 74 Lownie JF, Lownie MA, Reinach SG. Comparison of the safety and efficacy of a combination analgesic Myprodol and Ponstan in the treatment of dental pain. The Journal of the Dental Association of South Africa = Die Tydskrif van die Tandheelkundige Vereniging van Suid-Afrika 1992. link 75 Tolksdorf W, Siefert S. Drug-related methods for alleviation of stress in dentistry. Anesthesia & pain control in dentistry 1992. link 76 Ravic M, Johnston A, Turner P, Takacs F, Rosenow DE. The effect of repeated oral doses of lornoxicam on antipyrine elimination in normal human volunteers. Human & experimental toxicology 1991. link 77 Swapp KM. Drugs and the geriatric patient. A dental hygiene perspective. Journal of dental hygiene : JDH 1990. link 78 Hussain MA, Aungst BJ, Koval CA, Shefter E. Improved buccal delivery of opioid analgesics and antagonists with bitterless prodrugs. Pharmaceutical research 1988. link 79 Boerlin V, Maeglin B, Hägler W, Kuhn M, Nüesch E. Analgesic activity of propyphenazone in patients with pain following oral surgery. European journal of clinical pharmacology 1986. link 80 Henrikson PA, Thilander H, Wåhlander LA. Voltaren as an analgesic after surgical removal of a lower wisdom tooth. International journal of oral surgery 1985. link80022-3) 81 Leguen MA. Single-blind clinical trial comparing use of fentiazac and paracetamol in postendodontic periodontitis. Clinical therapeutics 1985. link 82 Francisco JV. Fentiazac as an oral analgesic for postoperative dental pain. Clinical therapeutics 1984. link 83 Squires DJ, Masson EL. A double-blind comparison of ibuprofen, ASA-codeine-caffeine compound and placebo in the treatment of dental surgery pain. The Journal of international medical research 1981. link 84 Cottone JA, Kafrawy AH. Medications and health histories: a survey of 4,365 dental patients. Journal of the American Dental Association (1939) 1979. link 85 Wright CJ. Analgesia following oral surgery for day patients: a clincial comparison of two analgesics. Current medical research and opinion 1977. link

Original source

[1]
Pharmacologic Management of Non-Traumatic Dental Conditions in US Emergency Departments, 2018-2022. — Leinbach LI, Li X, Iafolla T, Alraqiq H Journal of public health dentistry (2025)
[2]
Facts and trends in dental antibiotic and analgesic prescriptions in Germany, 2012-2021. — Albrecht H, Schiegnitz E, Halling F Clinical oral investigations (2024)
[3]
Dentists' attitudes and prescription practices for analgesics and antibiotics in Kirkuk Governorate, Iraq. — Mahdi ZA, Ibrahim JA Journal of medicine and life (2023)
[4]
High prescribing of antibiotics is associated with high prescribing of opioids in medical and dental providers. — Evans CT, Fitzpatrick MA, Poggensee L, Gonzalez B, Gibson G, Jurasic MM et al. Pharmacotherapy (2022)
[5]
Safe use of paracetamol and high-dose NSAID analgesia in dentistry during the COVID-19 pandemic. — Crighton AJ, McCann CT, Todd EJ, Brown AJ British dental journal (2020)
[6]
Nonsteroidal Anti-Inflammatory Drugs and Opioids in Postsurgical Dental Pain. — Hersh EV, Moore PA, Grosser T, Polomano RC, Farrar JT, Saraghi M et al. Journal of dental research (2020)
[7]
Antibiotic and opioid prescribing for dental-related conditions in emergency departments: United States, 2012 through 2014. — Roberts RM, Bohm MK, Bartoces MG, Fleming-Dutra KE, Hicks LA, Chalmers NI Journal of the American Dental Association (1939) (2020)
[8]
Trends in self-medication for dental conditions among patients attending oral health outreach programs in coastal Karnataka, India. — Simon AK, Rao A, Rajesh G, Shenoy R, Pai MB Indian journal of pharmacology (2015)
[9]
Adverse drug reactions in dental practice. — Becker DE Anesthesia progress (2014)
[10]
Comparison of the effects of ibuprofen and acetaminophen on PGE2 levels in the GCF during orthodontic tooth movement: a human study. — Shetty N, Patil AK, Ganeshkar SV, Hegde S Progress in orthodontics (2013)
[11]
Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo. — Kats A, Båge T, Georgsson P, Jönsson J, Quezada HC, Gustafsson A et al. FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2013)
[12]
Systemic health implications of dental prescribing in general practices. — Li S, Huang X, McNeil R, Malmstrom H, Ren Y Quintessence international (Berlin, Germany : 1985) (2026)
[13]
Cannabidiol - an effective analgesic for toothache? — Murphy S, Hayes E Evidence-based dentistry (2024)
[14]
Orofacial antinociceptive effects of perillyl alcohol associated with codeine and its possible modes of action. — Limeira RRT, Dantas NV, Tomaz-Morais JF, Costa TKVLD, Braga RM, Sousa FB et al. Brazilian oral research (2022)
[15]
Influence of Genetic Polymorphisms on the Response to Tramadol, Ibuprofen, and the Combination in Patients With Moderate to Severe Pain After Dental Surgery. — Saiz-Rodríguez M, Valdez-Acosta S, Borobia AM, Burgueño M, Gálvez-Múgica MÁ, Acero J et al. Clinical therapeutics (2021)
[16]
The use of anti-inflammatory drugs to prevent bleaching-induced tooth sensitivity is ineffective and unnecessary. — Markowitz K, Strickland M Evidence-based dentistry (2020)
[17]
Efficacy and Safety of Two Fixed-Dose Combinations of Tramadol Hydrochloride and Diclofenac Sodium in Postoperative Dental Pain. — Desjardins P, Alvarado F, Gil M, González M, Guajardo R Pain medicine (Malden, Mass.) (2020)
[18]
Effects of none-steroidal anti-inflammatory and antibiotic drugs on the oral immune system and oral microbial composition in rats. — Cheng X, Huang F, Zhang K, Yuan X, Song C Biochemical and biophysical research communications (2018)
[19]
Dentists' prescribing of antibiotics and opioids to Medicare Part D beneficiaries: Medications of high impact to public health. — Koppen L, Suda KJ, Rowan S, McGregor J, Evans CT Journal of the American Dental Association (1939) (2018)
[20]
Antibiotic and Opioid Analgesic Prescribing Patterns of Dentists in Vancouver and Endodontic Specialists in British Columbia. — Buttar R, Aleksejūnienė J, Coil J Journal (Canadian Dental Association) (2017)
[21]
Prescribing patterns of analgesics and other medicines by dental practitioners in Australia from 2001 to 2012. — Hollingworth SA, Chan R, Pham J, Shi S, Ford PJ Community dentistry and oral epidemiology (2017)
[22]
Development and characterization of a mucoadhesive sublingual formulation for pain control: extemporaneous oxycodone films in personalized therapy. — Parodi B, Russo E, Baldassari S, Zuccari G, Pastorino S, Yan M et al. Drug development and industrial pharmacy (2017)
[23]
The effect of benzocaine and ketoprofen gels on pain during fixed orthodontic appliance treatment: a randomised, double-blind, crossover trial. — Eslamian L, Borzabadi-Farahani A, Gholami H Australian orthodontic journal (2016)
[24]
Practice of Self-Medication for Dental Problems in Uttar Pradesh, India. — Jain A, Bhaskar DJ, Gupta D, Agali C, Yadav P, Khurana R Oral health & preventive dentistry (2016)
[25]
Three Serious Drug Interactions that Every Dentist Should Know About. — Hersh EV, Moore PA Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995) (2015)
[26]
Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young children. — Lavonas EJ, Banner W, Bradt P, Bucher-Bartelson B, Brown KR, Rajan P et al. The Journal of pediatrics (2013)
[27]
Analysis of effect of non-steroidal anti-inflammatory drugs on teeth and oral tissues during orthodontic treatment. Report based on literature review. — Krasny M, Zadurska M, Cessak G, Fiedor P Acta poloniae pharmaceutica (2013)
[28]
Effectiveness of an educational feedback intervention on drug prescribing in dental practice. — Rauniar GP, Das BP, Manandhar TR, Bhattacharya SK Kathmandu University medical journal (KUMJ) (2012)
[29]
Oral drug provocation test to generate a list of safe drugs: experience with 100 patients. — Ramam M, Kumar U, Bhat R, Sharma VK Indian journal of dermatology, venereology and leprology (2012)
[30]
Interpretation of oxycodone concentrations in oral fluid. — Moore C, Kelley-Baker T, Lacey J Journal of opioid management (2012)
[31]
Therapeutic efficacy and tolerability of the topical treatment of inflammatory conditions of the oral cavity with a mouthwash containing diclofenac epolamine: a randomized, investigator-blind, parallel-group, controlled, phase III study. — Serafini G, Trevisan S, Saponati G, Bandettini B Clinical drug investigation (2012)
[32]
The impact of drug samples on clinical recommendations in dental education. — Hujoel PP, Gillette J Journal of dental education (2011)
[33]
Potentially serious drug-drug interactions among community-dwelling older adult dental patients. — Skaar DD, O'Connor H Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics (2011)
[34]
Effects of analgesics on orthodontic pain. — Patel S, McGorray SP, Yezierski R, Fillingim R, Logan H, Wheeler TT American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics (2011)
[35]
Comparison of oral versus sublingual piroxicam during postoperative pain management after lower third molar extraction. — Trindade PA, Giglio FP, Colombini-Ishikiriama BL, Calvo AM, Modena KC, Ribeiro DA et al. International journal of oral and maxillofacial surgery (2011)
[36]
Efficacy and acceptability of 0.074% diclofenac-containing mouthwash after periodontal surgery: a clinical study. — Agarwal S, Mathur S, Kothiwale S, Benjamin A Indian journal of dental research : official publication of Indian Society for Dental Research (2010)
[37]
Analgesic efficacy of lysine clonixinate, paracetamol and dipyrone in lower third molar extraction: a randomized controlled trial. — Noronha VR, Gurgel GD, Alves LC, Noman-Ferreira LC, Mendonça LL, Aguiar EG et al. Medicina oral, patologia oral y cirugia bucal (2009)
[38]
Effects of combination treatment with ketoprofen 100 mg + acetaminophen 1000 mg on postoperative dental pain: a single-dose, 10-hour, randomized, double-blind, active- and placebo-controlled clinical trial. — Akural EI, Järvimäki V, Länsineva A, Niinimaa A, Alahuhta S Clinical therapeutics (2009)
[39]
Gender differences in analgesia for endodontic pain. — Ryan JL, Jureidini B, Hodges JS, Baisden M, Swift JQ, Bowles WR Journal of endodontics (2008)
[40]
Drug utilization pattern in dental outpatients in tertiary care teaching hospital in western Nepal. — Palaian S, Shankar PR, Hegde C, Hegde M, Ojha P, Mishra P The New York state dental journal (2008)
[41]
Dentist-prescribed drugs and the patients receiving them. — Wall TP, Brown LJ, Zentz RR, Manski RJ The Journal of the American College of Dentists (2007)
[42]
Pharmacological management of acute dental pain. — Canavan D Journal of the Irish Dental Association (2007)
[43]
Determination of meperidine, tramadol and oxycodone in human oral fluid using solid phase extraction and gas chromatography-mass spectrometry. — Moore C, Rana S, Coulter C Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2007)
[44]
Comparison of oxycodone pharmacokinetics after buccal and sublingual administration in children. — Kokki H, Rasanen I, Lasalmi M, Lehtola S, Ranta VP, Vanamo K et al. Clinical pharmacokinetics (2006)
[45]
The use of COX-2 inhibitors for acute dental pain: A second look. — Huber MA, Terezhalmy GT Journal of the American Dental Association (1939) (2006)
[46]
Efficacy and tolerability of diclofenac potassium sachets in acute postoperative dental pain: a placebo-controlled, randomised, comparative study vs. diclofenac potassium tablets. — Hofele CM, Gyenes V, Daems LN, Stypula-Ciuba B, Wagener H, Siegel J et al. International journal of clinical practice (2006)
[47]
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction. — Graziani F, Corsi L, Fornai M, Antonioli L, Tonelli M, Cei S et al. Pharmacological research (2005)
[48]
The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases. — Salvi GE, Lang NP Current pharmaceutical design (2005)
[49]
The effect of a dexibuprofen mouth rinse on experimental gingivitis in humans. — Rosin M, Kähler ST, Hessler M, Schwahn Ch, Kuhr A, Kocher T Journal of clinical periodontology (2005)
[50]
The analgesic effect of etoricoxib relative to that of cetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction pain. — Malmstrom K, Ang J, Fricke JR, Shingo S, Reicin A Current medical research and opinion (2005)
[51]
The effect of systemic administration of ibuprofen in the experimental gingivitis model. — Sekino S, Ramberg P, Lindhe J Journal of clinical periodontology (2005)
[52]
A randomized crossover trial of tenoxicam compared with rofecoxib for postoperative dental pain control. — Zacharias M, De Silva RK, Herbison P, Templer P Anaesthesia and intensive care (2004)
[53]
The analgesic efficacy of intramuscular parecoxib sodium in postoperative dental pain. — Mehlisch DR, Desjardins PJ, Daniels S, Hubbard RC Journal of the American Dental Association (1939) (2004)
[54]
Richlocaine in combined therapy of periodontitis. — Popkov VI, Zadorozhnyi AV, Galenko-Yaroshevskii PA Bulletin of experimental biology and medicine (2003)
[55]
Comparison of the efficacy of oral midazolam alone versus midazolam and meperidine in the pediatric dental patient. — Musial KM, Wilson S, Preisch J, Weaver J Pediatric dentistry (2003)
[56]
Analgesic efficacy of low-dose diclofenac versus paracetamol and placebo in postoperative dental pain. — Kubitzek F, Ziegler G, Gold MS, Liu JM, Ionescu E Journal of orofacial pain (2003)
[57]
Effects of selective cyclooxygenase-2 inhibition on gingival tissue levels of prostaglandin E2 and prostaglandin F2alpha and clinical parameters of chronic periodontitis. — Vardar S, Baylas H, Huseyinov A Journal of periodontology (2003)
[58]
Dentistry and self-medication: a current challenge. — Hernandez-Juyol M, Job-Quesada JR Medicina oral : organo oficial de la Sociedad Espanola de Medicina Oral y de la Academia Iberoamericana de Patologia y Medicina Bucal (2002)
[59]
The efficacy of combination analgesic therapy in relieving dental pain. — Mehlisch DR Journal of the American Dental Association (1939) (2002)
[60]
Effectiveness of tramadol as an analgesic in oral surgery. — Kumara R, Zacharias M The New Zealand dental journal (2002)
[61]
Oral medications. — Albretsen JC The Veterinary clinics of North America. Small animal practice (2002)
[62]
Interaction between piroxicam and azithromycin during distribution to human periodontal tissues. — Malizia T, Batoni G, Ghelardi E, Baschiera F, Graziani F, Blandizzi C et al. Journal of periodontology (2001)
[63]
Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses. — Jaraiz V, Rodriguez C, San Andres MD, Gonzalez F, San Andres MI Journal of veterinary pharmacology and therapeutics (1999)
[64]
Examination of the polymorphism of piroxicam in connection with the preparation of a new "soft-patch" type pharmaceutical dosage form. — Csóka G, Balogh E, Marton S, Farkas E, Rácz I Drug development and industrial pharmacy (1999)
[65]
Benzydamine reduces prostaglandin production in human gingival fibroblasts challenged with interleukin-1 beta or tumor necrosis factor alpha. — Modéer T, Yucel-Lindberg T Acta odontologica Scandinavica (1999)
[66]
Pharmacokinetic and safety evaluations of ketoprofen gels in subjects with adult periodontitis. — Lawrence HP, Paquette DW, Smith PC, Maynor G, Wilder R, Mann GL et al. Journal of dental research (1998)
[67]
Clinical evaluation of systemic doxycycline and ibuprofen administration as an adjunctive treatment for adult periodontitis. — Ng VW, Bissada NF Journal of periodontology (1998)
[68]
Cocaine disposition in saliva following intravenous, intranasal, and smoked administration. — Cone EJ, Oyler J, Darwin WD Journal of analytical toxicology (1997)
[69]
Comparison of the analgesic effects of diflunisal and paracetamol in the treatment of postoperative dental pain. — Selçuk E, Gomel M, Bellibas SE, Köse T, Tuğlular I International journal of clinical pharmacology research (1996)
[70]
Self-medication for the control of dental pain: what are our patients taking? — Preshaw PM, Meechan JG, Dodd MD Dental update (1994)
[71]
Evaluation of piroxicam-beta-cyclodextrin, piroxicam, paracetamol and placebo in post-operative oral surgery pain. — Dolci G, Ripari M, Pacifici L, Umile A International journal of clinical pharmacology research (1994)
[72]
A clinical evaluation of non-steroidal anti-inflammatory drugs (NSAIDS) as adjuncts in the management of periodontal disease. — Aboul-Dahab O Egyptian dental journal (1993)
[73]
Drug prescription practices of hospital dentists. — Rutkauskas JS Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry (1993)
[74]
Comparison of the safety and efficacy of a combination analgesic Myprodol and Ponstan in the treatment of dental pain. — Lownie JF, Lownie MA, Reinach SG The Journal of the Dental Association of South Africa = Die Tydskrif van die Tandheelkundige Vereniging van Suid-Afrika (1992)
[75]
Drug-related methods for alleviation of stress in dentistry. — Tolksdorf W, Siefert S Anesthesia & pain control in dentistry (1992)
[76]
The effect of repeated oral doses of lornoxicam on antipyrine elimination in normal human volunteers. — Ravic M, Johnston A, Turner P, Takacs F, Rosenow DE Human & experimental toxicology (1991)
[77]
Drugs and the geriatric patient. A dental hygiene perspective. — Swapp KM Journal of dental hygiene : JDH (1990)
[78]
Improved buccal delivery of opioid analgesics and antagonists with bitterless prodrugs. — Hussain MA, Aungst BJ, Koval CA, Shefter E Pharmaceutical research (1988)
[79]
Analgesic activity of propyphenazone in patients with pain following oral surgery. — Boerlin V, Maeglin B, Hägler W, Kuhn M, Nüesch E European journal of clinical pharmacology (1986)
[80]
Voltaren as an analgesic after surgical removal of a lower wisdom tooth. — Henrikson PA, Thilander H, Wåhlander LA International journal of oral surgery (1985)
[81]
Single-blind clinical trial comparing use of fentiazac and paracetamol in postendodontic periodontitis. — Leguen MA Clinical therapeutics (1985)
[82]
Fentiazac as an oral analgesic for postoperative dental pain. — Francisco JV Clinical therapeutics (1984)
[83]
A double-blind comparison of ibuprofen, ASA-codeine-caffeine compound and placebo in the treatment of dental surgery pain. — Squires DJ, Masson EL The Journal of international medical research (1981)
[84]
Medications and health histories: a survey of 4,365 dental patients. — Cottone JA, Kafrawy AH Journal of the American Dental Association (1939) (1979)
[85]
Analgesia following oral surgery for day patients: a clincial comparison of two analgesics. — Wright CJ Current medical research and opinion (1977)